Labshake search
Citations for R&D Systems :
151 - 200 of 4941 citations for Pops Hrms Hch Clean Up Spike 13C6 99% 50X Stock 1 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2022Quote: ... then stained with 0.1 µg/sample Alexa Fluor 647-conjugated mouse-anti SARS-CoV-2 Spike S1 (R&D Systems, FAB105403R-100UG) at 4°C for 30 min in the dark ...
-
bioRxiv - Immunology 2023Quote: ... was pre-incubated with either 10 µl biotinylated SARS-CoV-2 spike protein (3 nM final concentration; R&D Systems cat# BT10549), or with 10 µl biotinylated irrelevant antigen (3 nM final concentration ...
-
bioRxiv - Immunology 2023Quote: ... Unpurified transient transfection supernatant samples (50 µl) were pre-incubated with biotinylated SARS-CoV-2 spike protein (R&D Systems cat# BT10549) (50 µl ...
-
bioRxiv - Microbiology 2024Quote: ... Cells were then stained for 30min on ice with Alexa-Fluor-488-conjugated mouse monoclonal antibody (mAb) directed against the SARS-CoV-2 spike protein (R&D systems; clone #1035206 ...
-
bioRxiv - Biochemistry 2019Quote: ... 1 mg/ml bovine serum albumin and 50 μg/ml salmon sperm DNA (R&D Systems, Minneapolis, MN). Fluorescence polarization data were fitted to Equation 1:
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/mL recombinant human insulin-like growth factor 1 (IGF-1) (R&D Systems, USA), and 10 μM SB431542 (Tocris ...
-
bioRxiv - Cancer Biology 2021Quote: ... and then supplemented with 1 µg/mL VEGF (R&D Systems), 1 µg/mL bFGF (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... 1 µg/ml recombinant murine CD40L (CD40L, R&D Systems; Biotechne) or 10 µg/ml LPS from Salmonella minnesota R595 (LPS ...
-
bioRxiv - Developmental Biology 2020Quote: ... 500 ng/mL R-spondin 1 (R&D Systems, #4645-RS), 100 ng/mL Noggin (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... 1 or 100 ng/mL human IFNλ3 (R&D systems, Biotechne) for 24 h ...
-
bioRxiv - Microbiology 2021Quote: ... 25 ng mL-1 IL-3 (203-GMP, R&D Systems), 2 mM GlutaMAX ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL recombinant human IGF-1 (R&D Systems, USA), and 200 ng/mL L-ascorbic acid (Sigma-Aldrich ...
-
bioRxiv - Microbiology 2021Quote: ... 1 ng/mL recombinant murine IL-1b (R&D system, USA) was supplemented in the medium ...
-
bioRxiv - Microbiology 2022Quote: Cultures were stained with 1 μg/mL HADA (R&D systems) for 15 minutes with rolling and incubation at 37°C ...
-
bioRxiv - Neuroscience 2020Quote: ... and 20 ng ml−1 of basic FGF (R&D Systems). Subsequently neurospheres were seeded on polyornithine/laminin-coated dishes to form rosettes that were manually picked ...
-
bioRxiv - Cancer Biology 2021Quote: ... and FGF2 (20 ng ml–1, R&D Systems, 233-FB), and changed every day until day 15 ...
-
bioRxiv - Cell Biology 2022Quote: ... or CD14 (R&D systems, 982-CD-100, 1 mg/mL). Strips were washed 3 × (5 minutes agitation each ...
-
bioRxiv - Microbiology 2022Quote: Cultures were stained with 1 μg/mL HADA (R&D systems) for 15 minutes with rolling and incubation at 37°C ...
-
bioRxiv - Biophysics 2023Quote: ... either with 10 μg/mL human ICAM-1 (R&D Systems), 1 μg/mL CCL21 (Miltenyi biotech ...
-
bioRxiv - Neuroscience 2023Quote: ... and FGF2 (20 ng ml−1, R&D Systems, 233-FB) every day until day 15 ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL−1 Activin A (338-AC, R&D Systems) was added for three days ...
-
bioRxiv - Cancer Biology 2023Quote: ... goat polyclonal anti-CD276 (1 µg/ml; R&D systems, #AF1027), rabbit monoclonal anti-CD3 (1:200 ...
-
bioRxiv - Bioengineering 2023Quote: ... and 0.2 ng mL−1 basic FGF-2 (R&D systems). Half of the medium was changed on day 3 ...
-
bioRxiv - Cancer Biology 2023Quote: ... R-Spondin 1 (R&D Systems 3474-RS; 250 ng/ml) and N-acetylcysteine (A0737 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.5% BSA plus 0.1/1 μg/mL CCL21 (R&D systems) was added to basolateral chambers ...
-
bioRxiv - Immunology 2020Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (R&D Systems, Minneapolis, USA), and separately in combination with IL-4 and IL-21 (100 IU each) ...
-
bioRxiv - Immunology 2020Quote: ... anti-CD28 (1 µg/ml, clone CD28.2, eBioscience) and immobilized recombinant ICAM1-Fc fusion protein (0.5µg/ml, R&D Systems) in complete RPMI/HS medium ...
-
bioRxiv - Bioengineering 2023Quote: ... Organoid basal growth media was supplemented with epidermal growth factor (EGF) (100 ng/mL, 10 ng/mL, 1 ng/mL R&D Systems Cat#236-EG-01M) or Epiregulin (EREG ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Human ACE2 Biotinylated Antibody (Cat # BAF933) and Recombinant Spike S1 RBD protein (Cat # NBP2-90982) were obtained from R&D Systems (Minneapolis, MN, 55413) and NOVUS Biologicals (Centennial ...
-
bioRxiv - Bioengineering 2019Quote: ... we mixed laminin at 50 µg/mL with 50 µg/mL recombinant nidogen-1 (R&D systems 2570-Nd-050). Samples were immunostained as described below.
-
bioRxiv - Microbiology 2021Quote: ... 1 U/ml penicillin/streptomycin) with 3 ng/ml recombinant mouse GM-CSF (rGM-CSF; R&D Systems or BioLegend)) at a concentration of 2.5 x 105 cells/ml in 150 x 15 mm petri plates at 37°C with 5% CO2 ...
-
bioRxiv - Immunology 2022Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (both R&D Systems, Minneapolis, USA), and Type B CpG OND D-SL01 (InvivoGen ...
-
bioRxiv - Microbiology 2021Quote: ... 10ng/ml interleukin 4 (IL-4) and 10ng/ml transforming growth factor beta 1 (TGFβ1) (R&D systems, Minneapolis, MN), and used between days 7-9 of differentiation.
-
bioRxiv - Cancer Biology 2023Quote: ... in High Glucose DMEM supplemented with 10% FBS and 10ng/mL Recombinant Mouse CSF-1 (R&D Systems, #416-ML) for 7 days.
-
bioRxiv - Immunology 2022Quote: ... anti-IL-10 (50 μg ml−1, clone JES052A5, R&D Systems) and stimulated with polyclonal anti-CD3 (1 μg ml−1 ...
-
bioRxiv - Systems Biology 2019Quote: ... anti-IFN-γ (1 μg/ml R&D Systems Cat#MAB-285).
-
bioRxiv - Biophysics 2021Quote: ... 1 μg/mL epidermal growth factor (EGF) (R&D Systems, #236-EG10), 10 μM ionomycin (Iono ...
-
bioRxiv - Neuroscience 2022Quote: ... cultures were treated with IGF2 (R&D Systems; 100 ng ml−1), the PI3K/Akt inhibitor LY294002 (Sigma ...
-
bioRxiv - Immunology 2020Quote: ... or a combination of 2 µg/ml ICAM-1 (R&D Systems), 1 µg/ml NKp30 (R&D systems ...
-
bioRxiv - Cell Biology 2019Quote: ... 1 mM glutamine supplemented with either Bmp4 (100ng/ml; R&D Systems) or FBS (10%).
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant Mouse IGF-I/IGF-1 Protein (10ng/ml, R&D Systems), Transforming Growth Factor (TGF)β1 (10ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-6 (1000 U/mL; R&D Systems Cat# 206–1 L), and PGE2 (2 μM ...
-
bioRxiv - Cell Biology 2021Quote: ... or Ephrin A5 (1 µg/ml, R&D Systems, Cat. 374-EA) for 1 ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 25 ng ml-1 FGF4 (R&D Systems 7486-F4-025) for three days (with Y-27632 added for the first 24 hours only) ...
-
bioRxiv - Cell Biology 2022Quote: ... 1% ITS+premix and 100ng/ml recombinant CCL2 protein (R&D Systems) or 1% BSA for the control were placed on uncoated or Matrigel coated inserts in the upper compartment ...
-
bioRxiv - Cell Biology 2022Quote: ... and 100 ng ml-1 FGF8a (4745-F8-050, R&D Systems). On day 16-17 ...
-
bioRxiv - Immunology 2023Quote: ... were coated with human ICAM-1 (3 μg/mL; R&D system) overnight at 4°C ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 1 µg/mL laminin-I (R&D Systems; #3446-005-01). Cells were passaged every second day by dissociation with accutase (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2023Quote: ... sFRP2 (cat. no. 6838-FR, R&D Systems, 60 ng ml−1) and KN93 (cat ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 ng mL− 1 FGF-10 (human recombinant) (R&D Systems). The cells were then treated with RPMI medium GlutaMax™ Supplement containing 2% (v/v ...